Forward Management’s GSK GSK Stock Holding History

Forward Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,750	Closed	-$690K	–	79
2018 Q3	$690K	Sell	13,750 -12,505	-48%	-$635K	0.12%	85
2018 Q2	$1.32M	Sell	26,255 -3,858	-13%	-$194K	0.22%	61
2018 Q1	$1.47M	Buy	30,113 +2,215	+8%	+$103K	0.21%	60
2017 Q4	$1.24M	Sell	27,898 -2,048	-7%	-$94.6K	0.14%	87
2017 Q3	$1.52M	Sell	29,946 -9,361	-24%	-$475K	0.17%	79
2017 Q2	$2.12M	Sell	39,307 -6,964	-15%	-$371K	0.18%	72
2017 Q1	$2.44M	Sell	46,271 -8,106	-15%	-$411K	0.21%	65
2016 Q4	$2.62M	Sell	54,377 -2,537	-4%	-$125K	0.18%	83
2016 Q3	$3.07M	Buy	56,914 +17,823	+46%	+$977K	0.23%	59
2016 Q2	$2.12M	Buy	39,091 +38,883	+18,694%	+$2.05M	0.18%	66
2016 Q1	$11K	Buy	+208	New	+$10.4K	﹤0.01%	233

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Forward Management's GSK Position: Q4 2018 in Review

Forward Management sold out of GSK (GSK) in Q4 2018, closing a stake of 13,750 shares — an estimated $690K sold.

Forward Management first reported a position in GSK in Q1 2016 and held it in 11 quarters. The position peaked at $3.07M in Q3 2016. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Forward Management reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Forward Management sold 13,750 GSK shares in Q4 2018, an estimated $690K.
Forward Management first reported a position in GSK in Q1 2016 and held it in 11 quarters.
Forward Management's GSK position peaked at $3.07M in Q3 2016.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Forward Management's 13F filing for Q4 2018, filed 1 Feb 2019.